Increasing Predictability - Clinical studies don’t meet their patient enrollment timelines 80% of the time. PAREXEL…
You now have access to all the content in the PAREXEL Consulting Regulatory Portal. We look forward to engaging with you.
We will be in touch shortly.
Please complete our registration form to continue.
How will RWD (real world data) be affected by the growth of wearables, biosensors, smart devices and apps? How will the use of RWD change utilization of Real World Evidence for access evaluation, and clinical development? Can access to this data change the use of information to engaging stakeholders and activate them to take action at the sub-population and broader level? Is this new trove of information able to change the threshold for evidence for access decisions and will it impact the definition of value moving forward?
Click below to find out more.
Managing and monitoring your site training and compliance is not always easy. Clinical teams face enormous pressures and…
This year’s trending topics are sure to raise eyebrows with pharmaceutical industry headlines discussing the use of…
Data Analytics and Insights